I

Immatics NV

D
IMTX
USD
-0.1
(-1.0684%)
Market Closed
10,687.00
Volume
EPS
-
Div Yield
-10.329586
P/E
954,760,689.56
Market Cap
Today
-1.0684%
1 Week
1.647%
1 Month
-15.356%
6 Months
-13.458%
12 Months
-7.028%
Year To Date
-12.061%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRNA
MRNA
-1.49
(-2.8776%)
USD
B
BNTX
0.99
(0.9269%)
USD
N
NVAX
0.23
(2.5713%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
REGN
REGN
8.505
(1.0417%)
USD
MRK
MRK
0.46
(0.4567%)
USD
PFE
PFE
0.105
(0.3839%)
USD
GSK
GSK
0.76
(2.117%)
USD
AZN
AZN
0.835
(1.308%)
USD
JNJ
JNJ
-1.03
(-0.6528%)
USD

Title:
Immatics NV

Sector:
Healthcare
Industry:
Biotechnology
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Do you need help or have a question?
Contact Us